Mark Andrew Wilson, Chief Legal Officer at NEKTAR THERAPEUTICS (NKTR), sold 630 shares at $54.28 ($34K) on 2025-11-25, disclosed to the SEC on 2025-11-25.
Seasonal sale ($34k) by Chief Legal Officer — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |
| NKTR | SELL | 2024-11-20 | $6K | — | Filing → |